Brevan Howard Capital Management LP MRVI — Maravai LifeSciences Holdings Inc

Ownership history in Brevan Howard Capital Management LP  ·  3 quarters on record

AI Ownership Summary

Brevan Howard Capital Management LP reported Maravai LifeSciences Holdings Inc (MRVI) in 3 quarterly 13F filings from 2023 Q4 through 2026 Q1. The latest visible filing shows MRVI at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this MRVI ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Brevan Howard Capital Management LP's position in Maravai LifeSciences Holdings Inc, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

MRVI was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2023 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

MRVI stock page Brevan Howard Capital Management LP fund profile Brevan Howard Capital Management LP full holdings
How Brevan Howard Capital Management LP held MRVI — position size vs. price
% of Fund (quarterly)    MRVI price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 3 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 REDUCED — — — 10,090 -14,003 -58.1% 0.00% $29K 2026-05-15 $4.15
2025 Q3 ADDED — — — 24,093 +1,679 +7.5% 0.00% $69K 2025-11-14 $3.64
2023 Q4 INITIATED — — — 22,414 — — 0.00% $147K 2024-02-14 $5.15

🏢 Other funds also holding MRVI

As of 2026 Q1 — sorted by position size

Brummer Multi-Strategy AB 8.95% 12 West Capital Management LP 3Y 7Y 3.47% Tejara Capital Ltd 3Y 3.26% Monaco Asset Management SAM 3Y 1.79% GTCR LLC 3Y 1.51% BRAIDWELL LP 3Y 0.97% Philosophy Capital Management LLC 3Y 0.46% GENERAL AMERICAN INVESTORS CO INC 3Y 7Y 0.32% Alpine Peaks Capital, LP 3Y 0.29% EPACRIA CAPITAL PARTNERS, LLC 3Y 0.22%

FAQ About Brevan Howard Capital Management LP and MRVI

These are the practical questions this page is built to answer before you even open the full history table.

How long has Brevan Howard Capital Management LP reported owning MRVI?

Brevan Howard Capital Management LP reported MRVI across 3 quarterly 13F filings, from 2023 Q4 through 2026 Q1.

What was the largest reported MRVI position in Brevan Howard Capital Management LP's portfolio?

The largest reported portfolio weight for MRVI was 0.00% in 2023 Q4.

What is the latest reported MRVI position on this page?

The most recent filing on this page is 2026 Q1, when Brevan Howard Capital Management LP reported 10,090 shares, equal to 0.00% of portfolio, with an estimated market value of $29K.

What does the chart on this MRVI ownership page compare?

The chart compares Brevan Howard Capital Management LP's quarterly MRVI portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to Brevan Howard Capital Management LP Holdings